Placebo Controlled Proof of Concept Study to Investigate ANB020 Activity in Adult Patients With Severe Eosinophilic Asthma
Phase of Trial: Phase II
Latest Information Update: 24 Sep 2018
At a glance
- Drugs Etokimab (Primary)
- Indications Asthma
- Focus Adverse reactions; Proof of concept; Therapeutic Use
- Sponsors AnaptysBio
- 24 Sep 2018 According to an AnaptysBio media release, the company plans to report full data from this trial at a medical conference in 2019 following trial completion.
- 24 Sep 2018 Topline interim analysis results, presented in a AnaptysBio media release.
- 26 Mar 2018 According to an AnaptysBio media release, top-line data are anticipated in the third quarter of 2018.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History